Gordon Treadway

President at Culture Partners

Health Technology

Consumer Services

Commercial Services

Profile

Gordon Treadway is currently the President at Culture Partners.
Previously, he worked as the Vice President-Sales at Tercica, Inc. from 2007 to 2014.
He completed his undergraduate degree at Brigham Young University.

Gordon Treadway active positions

Companies	Position	Start
Culture Partners Culture Partners Miscellaneous Commercial ServicesCommercial Services Culture Partners engages in the provision of accountability training and consulting services. Its practice areas are accountability, accelerating culture change, employee engagement, execution and implementation, executive team alignment, information technology culture, and leadership development. The company was founded by Roger Connors and Tom Smith in 1989 and is headquartered in Temecula, CA.	President	2012-12-31

All active positions of Gordon Treadway

Former positions of Gordon Treadway

Companies	Position	End
Tercica, Inc. Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc.	Sales & Marketing	2014-02-02

See the detail of Gordon Treadway's experience

Training of Gordon Treadway

Brigham Young University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gordon Treadway's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Tercica, Inc. Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc.	Health Technology
Culture Partners Culture Partners Miscellaneous Commercial ServicesCommercial Services Culture Partners engages in the provision of accountability training and consulting services. Its practice areas are accountability, accelerating culture change, employee engagement, execution and implementation, executive team alignment, information technology culture, and leadership development. The company was founded by Roger Connors and Tom Smith in 1989 and is headquartered in Temecula, CA.	Commercial Services